Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky Roy

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nature Communications|October 20, 2020
Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancyAlex W Wessel, Nurgun Kose, Robin G Bombardi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
IgA-driven neutrophil activation underlies post-Zika severe dengue disease in humansJaime A Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, et al.
The Journal of Infectious Diseases|July 14, 2019
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody ResponsesBronwyn M Gunn, Vicky Roy, Marcus M Karim, et al.
Nature Immunology|January 2, 2026
IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humansJaime A Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, et al.
Frontiers in Immunology|March 11, 2022
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV ChallengesSamir K Lakhashe, Mario Amacker, Dinesh Hariraju, et al.
Journal of Immunological Methods|August 12, 2020
SARS-CoV-2-specific ELISA developmentVicky Roy, Stephanie Fischinger, Caroline Atyeo, et al.
Med (New York, N.Y.)|November 19, 2025
Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma developmentVicky Roy, Benjamin P Kellman, Wan-Lun Hsu, et al.
Mbio|August 3, 2023
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concernRyan P McNamara, Jenny S Maron, Julie Boucau, et al.
NPJ Vaccines|January 20, 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nature Communications|October 20, 2020
Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancyAlex W Wessel, Nurgun Kose, Robin G Bombardi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
IgA-driven neutrophil activation underlies post-Zika severe dengue disease in humansJaime A Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, et al.
The Journal of Infectious Diseases|July 14, 2019
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody ResponsesBronwyn M Gunn, Vicky Roy, Marcus M Karim, et al.
Nature Immunology|January 2, 2026
IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humansJaime A Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, et al.
Frontiers in Immunology|March 11, 2022
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV ChallengesSamir K Lakhashe, Mario Amacker, Dinesh Hariraju, et al.
Journal of Immunological Methods|August 12, 2020
SARS-CoV-2-specific ELISA developmentVicky Roy, Stephanie Fischinger, Caroline Atyeo, et al.
Med (New York, N.Y.)|November 19, 2025
Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma developmentVicky Roy, Benjamin P Kellman, Wan-Lun Hsu, et al.
Mbio|August 3, 2023
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concernRyan P McNamara, Jenny S Maron, Julie Boucau, et al.
NPJ Vaccines|January 20, 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Pageof 3